ConductScience.org, home

Comparison · NCT05327296-a66238e4

Isoflurane (Run-ins and Randomized) vs Propofol: Other Secondary: The Use of Restraints in Patients Receiving Isoflurane vs Propofol

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Isoflurane (Run-ins and Randomized) vs Propofol: Other Secondary: The Use of Restraints in Patients Receiving Isoflurane vs Propofol. Trial comparisons, record NCT05327296-a66238e4. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05327296-a66238e4

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.7980.7320.851wilson
Risk in group 20.8390.7480.902wilson
Risk difference, group 1 minus group 2-0.0414-0.1320.0642newcombe hybrid score
Risk ratio, group 1 over group 20.9510.8441.07log
Odds ratio, group 1 over group 20.7560.3821.49log
Number needed to treat, for one fewer participant with the outcome on Isoflurane (Run-ins and Randomized) than on Propofol24.2from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Isoflurane (Run-ins and Randomized)Inhaled isoflurane administered via Sedaconda ACD-S~3-5 run-in patients treated with isoflurane were enrolled at each site prior to randomization138173OG000
Group 2PropofolPropofol administered as intravenous infusion~Propofol: Intravenous infusion of propofol7387OG001

Outcome

Type
SECONDARY
Title
Other Secondary: The Use of Restraints in Patients Receiving Isoflurane vs Propofol
Description
Incidence of restraints measured twice daily
Time frame
From start to end of study treatment (up to 48 (±6) hours)
Population
This Outcome Measure was pre-specified to be assess based on the Safety Population (run-in patients and Randomized participants that received any study drug)

Source ClinicalTrials.gov

Trial

Title
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
NCT number
NCT05327296
Phases
PHASE3
Conditions
Sedation
Interventions
Isoflurane, Propofol
Lead sponsor
Sedana Medical
Results first posted
2026-03-03

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT05327296-a66238e4